{"id":"W4205561311","doi":"10.1200/jco.21.02647","title":"Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; McMaster University; London Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Adjuvant; Denosumab; Bisphosphonate; Breast cancer; Adjuvant therapy; Guideline; Exemestane; Zoledronic acid","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008538714,0.0008850258,0.001766409,0.004463996,0.0004873196,0.0017207,0.002728845,0.002648949,0.002731328],"category_scores_gemma":[0.02221836,0.0004937958,0.003116735,0.004949575,0.0004544625,0.001417737,0.001187602,0.002252222,0.001317631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004454474,"about_ca_system_score_gemma":0.01756732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03829914,"about_ca_topic_score_gemma":0.09179178,"domain_scores_codex":[0.9933153,0.002026755,0.001800399,0.0002714333,0.002263404,0.0003227546],"domain_scores_gemma":[0.9825211,0.004405065,0.003172022,0.0002579928,0.009096006,0.0005478285],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001409188,0.00009654379,0.003070135,0.05166709,0.0007828549,0.0001679209,0.0002624773,0.0006313194,0.0004911949,0.001910541,0.5502663,0.3905128],"study_design_scores_gemma":[0.0003252006,0.0001214624,0.007736835,0.126842,0.002963656,0.0005550481,0.000203301,0.0004363373,0.0003149342,0.001830779,0.8586082,0.00006225644],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.003665877,0.8495768,0.00325228,0.09692958,0.007399059,0.002025424,0.01106215,0.0002220685,0.02586673],"genre_scores_gemma":[0.01785588,0.8841802,0.02581993,0.04362183,0.003763729,0.002537476,0.01531466,0.00009686723,0.006809355],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.03829914,"threshold_uncertainty_score":0.07615244,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2150645759624845,"score_gpt":0.5088892296439328,"score_spread":0.2938246536814483,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}